Citations

Clear

2429 citation(s) found for "Shah, SS".

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
Yao, James C. , Baudin, Éric , Kvols, Larry K., Rougier, Philippe, Ruszniewski, Philippe, Hoosen, Sakina, Peter, J., Haas, T , Lebwohl, David , Kulke, Matthew H. , Hobday, Timothy J. , O’Dorisio, Thomas M. , Shah, Manisha H. , Cadiot, Guillaume , Luppi, Gabriele , Posey, James , Wiedenmann, Bertram , Lombard‐Bohas, Catherine , Cutsem, Eric Van

Mayo Clinic

Journal of Clinical Oncology | November 23, 2009 | Volume: 28 | Issue: 1 | Pages: 69-76

10.1200/jco.2009.24.2669 | PMID 19933912 Get It

Purpose No established treatment exists for pancreatic neuroendocrine tumor (NET) progression after failure of chemotherapy. Everolimus (RAD001), an oral inhibitor of mammalian target of rapamycin, in combination with octreotide has demonstrated encouraging antitumor activity in patients with NETs. Patients and Methods This open-label, phase II study assessed the clinical activity of everolimus in patients with metastatic pancreatic NETs who experienced progression on or after chemotherapy. Patients were stratified by prior octreotide therapy (stratum 1: everolimus 10 mg/d, n = 115; stratum 2: everolimus 10 mg/d plus octreotide long-acting release [LAR], n = 45). Tumor assessments (using Response Evaluation Criteria in Solid Tumors) were performed every 3 months. Chromogranin A (CgA) and neuron-specific enolase (NSE) were assessed monthly if elevated at baseline. Trough concentrations of everolimus and octreotide were assessed. Results By central radiology review, in stratum 1, there were 11 partial responses (9.6%), 78 patients (67.8%) with stable disease (SD), and 16 patients (13.9%) with progressive disease; median progression-free survival (PFS) was 9.7 months. In stratum 2, there were two partial responses (4.4%), 36 patients (80%) with SD, and no patients with progressive disease; median PFS was 16.7 months. Patients with an early CgA or NSE response had a longer PFS compared with patients without an early response. Coadministration of octreotide LAR and everolimus did not impact exposure to either drug. Most adverse events were mild to moderate and were consistent with those previously seen with everolimus. Conclusion Daily everolimus, with or without concomitant octreotide LAR, demonstrates antitumor activity as measured by objective response rate and PFS and is well tolerated in patients with advanced pancreatic NETs after failure of prior systemic chemotherapy.
Golf After Total Knee Arthroplasty
Jackson, Jeffrey D., Smith, Jay , Shah, Jay P. , Wisniewski, Stephen, Dahm, Diane L.

Mayo Clinic

The American Journal of Sports Medicine | August 14, 2009 | Volume: 37 | Issue: 11 | Pages: 2201-2204

10.1177/0363546509339009 | PMID 19684299 Get It

Background Golf provides an opportunity for relatively low-impact exercise for nearly all age groups and is considered a recommended activity for patients after total knee arthroplasty. Hypothesis We hypothesized that total knee arthroplasty would afford patients increased ability to participate in and enjoy golf, allowing a large percentage of these patients to walk the golf course. Study Design Case series; Level of evidence, 4. Methods Surveys were sent to 151 golfers who had undergone primary total knee arthroplasty from 1995 to 2000. The detailed survey included 33 questions specific to the patients’ golf performance, enjoyment of golf, frequency of participation, timing of return to play, presence of pain, use of a cart, and related golf-specific issues. Results We received and evaluated 93 responses (62%). Fifty-seven percent reported they had returned to golf within 6 months after total knee arthroplasty. Eighty-one percent of respondents reported golfing as frequently, or more frequently, than before knee replacement. Notably, golfers reported less pain while golfing after total knee arthroplasty than before (13% vs 83%; P < .0001), and 94% of respondents reported currently enjoying golf as much as or more than before surgery. Twenty-eight percent of respondents stated that they walked the course, rather than using a motorized golf cart, before surgery, while only 14% walked the course after surgery ( P = .02). Conclusion In this population of golfers, total knee arthroplasty reliably relieved pain that had been previously experienced while golfing, and increased or maintained this group’s enjoyment of playing golf. However, 86% of these patients reported using a cart while golfing. Further patient education is needed regarding the potential health benefits of walking during golf after total knee arthroplasty.
Should Clinicians Deliver Decision Aids? Further Exploration of the Statin Choice Randomized Trial Results
Jones, Lesley A., Weymiller, Audrey, Shah, Nilay D. , Bryant, Sandra C. , Christianson, Teresa J., Gafni, Amiram , Smith, Steven A., Montori, Víctor M. , Guyatt, Gordon , Montori, Victor M

Mayo Clinic

Medical Decision Making | July 15, 2009 | Volume: 29 | Issue: 4 | Pages: 468-474

10.1177/0272989x09333120 | PMID 19605885 Get It

Background. Statin Choice is a decision aid about taking statins. The optimal mode of delivering Statin Choice (or any other decision aid) in clinical practice is unknown. Methods. To investigate the effect of mode of delivery on decision aid efficacy, the authors further explored the results of a concealed 2 × 2 factorial clustered randomized trial enrolling 21 endocrinologists and 98 diabetes patients and randomizing them to 1) receive either the decision aid or pamphlet about cholesterol, and 2) have these delivered either during the office visit (by the clinician) or before the visit (by a researcher). We estimated between-group differences and their 95% confidence intervals (CI) for acceptability of information delivery (1—7), knowledge about statins and coronary risk (0—9), and decisional conflict about statin use (0—100) assessed immediately after the visit. Follow-up was 99%. Results. The relative efficacy of the decision aid v. pamphlet interacted with the mode of delivery. Compared with the pamphlet, patients whose clinicians delivered the decision aid during the office visit showed significant improvements in knowledge (difference of 1.6 of 9 questions, CI 0.3, 2.8) and nonsignificant trends toward finding the decision aid more acceptable (odds ratio 3.1, CI 0.9, 11.2) and having less decisional conflict (difference of 7 of 100 points, CI - 4, 18) than when a researcher delivered the decision aid just before the office visit. Conclusions. Delivery of decision aids by clinicians during the visit improves knowledge and shows a trend toward better acceptability and less decisional conflict.
Optimizing the Start Time of Statin Therapy for Patients with Diabetes
Denton, Brian T., Kurt, Murat , Shah, Nilay D., Bryant, Sandra C. , Smith, Steven A., Denton, Brian T.

Mayo Clinic

Medical Decision Making | May 8, 2009 | Volume: 29 | Issue: 3 | Pages: 351-367

10.1177/0272989x08329462 | PMID 19429836 Get It

Background . Clinicians often use validated risk models to guide treatment decisions for cardiovascular risk reduction. The most common risk models for predicting cardiovascular risk are the UKPDS, Framingham, and Archimedes models. In this article, the authors propose a model to optimize the selection of patients for statin therapy of hypercholesterolemia, for patients with type 2 diabetes, using each of the risk models. For each model, they evaluate the role of age, gender, and metabolic state on the optimal start time for statins. Method . Using clinical data from the Mayo Clinic electronic medical record, the authors construct a Markov decision process model with health states composed of cardiovascular events and metabolic factors such as total cholesterol and high-density lipoproteins. They use it to evaluate the optimal start time of statin treatment for different combinations of cardiovascular risk models and patient attributes. Results . The authors find that treatment decisions depend on the cardiovascular risk model used and the age, gender, and metabolic state of the patient. Using the UKPDS risk model to estimate the probability of coronary heart disease and stroke events, they find that all white male patients should eventually start statin therapy; however, using Framingham and Archimedes models in place of UKPDS, they find that for male patients at lower risk, it is never optimal to initiate statins. For white female patients, the authors also find some patients for whom it is never optimal to initiate statins. Assuming that age 40 is the earliest possible start time, the authors find that the earliest optimal start times for UKPDS, Framingham, and Archimedes are 50, 46, and 40, respectively, for women. For men, the earliest optimal start times are 40, 40, and 40, respectively. Conclusions . In addition to age, gender, and metabolic state, the choice of cardiovascular risk model influences the apparent optimal time for starting statins in patients with diabetes.
Operative management of the medial collateral ligament in the multi‐ligament injured knee: an evidence‐based systematic review
Kovachevich, Rudy, Shah, Jay P. , Arens, Ann M. , Dahm, Diane L., Levy, Bruce A. , Stuart, Michael J.

Mayo Clinic

Knee Surgery, Sports Traumatology, Arthroscopy | May 6, 2009 | Volume: 17 | Issue: 7 | Pages: 823-829

10.1007/s00167-009-0810-4 | PMID 19421735 Get It

AbstractWhile it is generally accepted that most partial and isolated medial collateral ligament (MCL) injuries can be treated non‐operatively, ideal treatment of the MCL in multi‐ligament knee injuries remains controversial. High failure rates with repair of the posterolateral corner in the multi‐ligament injured knee have been recently reported, favoring reconstruction instead. The same maybe true for MCL injuries, however evidence‐based treatment recommendations are lacking in the current orthopedic literature. The purpose of this study was to perform an evidence‐based systematic review of the operative management (repair and/or reconstruction) of the MCL in the setting of multi‐ligament knee injuries. A comprehensive search of MEDLINE and the Cochrane databases for all relevant articles published in English from 1978 to 2008 on the outcomes of surgical management (repair and/or reconstruction) of the MCL in the setting of combined ligament injuries was performed. Inclusion criteria included articles published in (1) English, (2) on human subjects, (3) between the years of 1978 and 2008, (4) had minimum 12‐month follow‐up, with a mean of at least 24 months, (5) on surgical management of MCL injuries, (6) associated with multi‐ligament injuries (three or more ligaments) and/or knee dislocation, and (7) reported objective outcome data on the respective patient cohorts. Exclusion criteria consisted of technique papers, case reports, studies that included fractures associated with MCL injury and those that included pediatric patients. The review identified eight relevant studies. Five articles focused on MCL repair, while three articles focused on MCL reconstruction. No prospective studies compared MCL repair or reconstruction with non‐operative treatment or directly compared MCL reconstruction with MCL repair. Currently there is a paucity of objective data on the outcomes regarding surgical management of MCL tears in the combined ligament injured knee. This systematic review demonstrated satisfactory results in both repair and reconstruction groups. Future objective outcome‐based studies as well as comparative studies are needed to further evaluate the optimal treatment modality before evidence‐based recommendations can be made. Therefore, individual treatment decisions for each patient should be based on the characteristics and nature of the injury.
Projecting future drug expenditures—2009
Hoffman, James M. , Shah, Nilay D., Vermeulen, Lee C. , Doloresco, Fred, Martin, Patrick K., Blake, S.J. Richard A., Matusiak, Linda M., Hunkler, Robert J., Schumock, Glen T.

Mayo Clinic

American Journal of Health-System Pharmacy | January 29, 2009 | Volume: 66 | Issue: 3 | Pages: 237-257

10.2146/ajhp080636 | PMID 19179637 Get It

FXR Promotes Endothelial Cell Motility Through Coordinated Regulation of FAK and MMP-9
Das, Amitava , Yaqoob, Usman , Mehta, Dolly , Shah, Vijay H. , Yaqoob, Usman

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | January 15, 2009 | Volume: 29 | Issue: 4 | Pages: 562-570

10.1161/atvbaha.108.182725 | PMID 19150878 Get It

Objective— Farnesoid X Receptor (FXR) mediates important signaling functions of bile acids in diverse cell types including those residing in the vascular wall. Indeed, recent work has identified FXR as a potential regulator of vascular structure and function in part through transcriptional activation of MMP-9. However, the signal transduction pathways linking bile acids to changes in actin cytoskeleton that are responsible for bile acid-induced vascular cell migration remain unexplored. Methods and Results— The FXR agonist and prototypical bile acid, chenodeoxycholic acid (CDCA), significantly increased endothelial cell (EC) motility, as analyzed by time lapse video microscopy, and tube formation, an in vitro correlate for angiogenesis. Increased cell motility was associated with prominent increases in focal adhesion (FA) plaques and was inhibited by FXR or MMP-9 siRNA, indicating a FXR-MMP-9-dependency of this signaling pathway. Mechanistically, incubation of cells with CDCA was associated with phosphorylation of a key FA protein, Focal Adhesion Kinase (FAK) at Y397 but not at Y576/577, or Y925. Studies using a site-specific phosphorylation mutant (phosphodeficient) of FAK revealed that FAK phosphorylation at tyrosine residue −397 was required for CDCA induced activation of the downstream FA assembly protein, paxillin. Lastly, siRNA-based silencing of FAK as well as phosphodeficient FAK mutant inhibited CDCA induced upregulation of MMP-9, cell motility, and vascular tube formation. Conclusion— Thus, this study demonstrates a pivotal role for FAK in the process of FXR-induced and MMP-9-dependent EC motility and vascular tube formation.
Achilles Tendon Allograft Reconstruction of the Fibular Collateral Ligament and Posterolateral Corner
Schechinger, Steve J., Levy, Bruce A. , Dajani, Khaled, Shah, Jay P. , Marx, Robert G. , Herrera, Diego Alberto

Mayo Clinic

Arthroscopy | November 21, 2008 | Volume: 25 | Issue: 3 | Pages: 232-242

10.1016/j.arthro.2008.09.017 | PMID 19245984 Get It

Purpose The purpose of this study was to investigate the functional and clinical outcomes of a consecutive series of patients who underwent fibular collateral ligament (FCL) and posterolateral corner (PLC) reconstruction by use of a single Achilles tendon allograft construct. Methods Patients were identified through prospective sports medicine databases at 2 academic institutions. Only patients who had undergone FCL and PLC reconstruction (as opposed to repair) were included. All patients followed a standard postoperative rehabilitation protocol. Various patterns of combined ligament injuries were included and divided into 2 groups (2 ligament v multiligament). Functional and clinical outcomes were assessed by clinical examination, Lysholm scores, and International Knee Documentation Committee subjective scores. Statistical analysis was performed by use of Wilcoxon paired rank‐sum tests and multivariate regression. Results We identified 16 knees in 16 patients, with a minimum of 2 years' follow‐up. There were 13 men and 3 women. The mean age was 30 years (range, 19 to 61 years). The mean length of clinical follow‐up was 30 months (range, 24 to 75 months). The mean International Knee Documentation Committee subjective scores were 80 points and 80 points ( P = .79) in the 2‐ligament and multiligament groups, respectively, and the mean Lysholm scores were 90 points and 89 points ( P = .96), respectively. Age ( P = .41), gender ( P = .84), and interval between injury and surgery ( P = .72) did not affect the clinical and functional outcomes between the 2 groups. Arthrofibrosis requiring manipulation developed in 1 patient. Residual varus laxity (1+) was noted in 4 patients, none of whom displayed functional instability. No patient has required revision reconstruction to date. Conclusions We describe a novel technique that takes into account the main static PLC stabilizers (FCL, popliteofibular ligament, and posterolateral capsule) that has not been previously reported. Our series showed no significant differences in clinical and functional outcomes between 2‐ligament and multiligament PLC‐based reconstructions. However, given the heterogeneity and small sample size of our study group, it is difficult to draw qualitative conclusions. Level of Evidence Level IV, therapeutic case series.
Prandial Insulin and the Systemic Appearance of Meal-Derived Glucose in People With Type 1 Diabetes
Shah, Pankaj, Basu, Ananda , Rizza, Robert A., Vella, Adrian

Mayo Clinic

Diabetes Care | October 27, 2008 | Volume: 31 | Issue: 11 | Pages: 2230-2231

10.2337/dc08-1549 | PMID 18955720 Get It

Subepicardial Aneurysm Evaluated by Multiplane 2D and Real-Time 3D Volumetric Transesophageal Echocardiography
Yang, Hyun Suk , Shah, Sairav B., Sweeney, John P., Khandheria, Bijoy K. , Chandrasekaran, Krishnaswamy

Mayo Clinic

Circulation: Cardiovascular Imaging | September 16, 2008 | Volume: 1 | Issue: 2 | Pages: 171-172

10.1161/circimaging.108.780833 | PMID 19808535 Get It